Showing 34,667 results

New & experimental hepatitis C treatment

Daclatasvir + asunaprevir + BMS-791352 looks promising as interferon-free combination

News
2 May 2013
Men who have sex with men (MSM)

Blackmail, violence and stigma restrict access to sexual health services for gay men, Global Health and Rights Study reports

News
1 May 2013
New & experimental hepatitis C treatment

Combination Drugs are the Future of the European Hepatitis B and C Therapeutics Markets

Editor's pick
PR Newswire
1 May 2013
Young people

Personal, social, health and economic education requires improvement in English schools

Editor's pick
OFSTED press release
1 May 2013
Pharmaceutical industry

Pharmaceutical Industry: The Doctor’s Dilemma

Editor's pick
The Global Mail
1 May 2013
Young people

New survey on HIV education: Progression, regression or stagnation?

Editor's pick
UNAIDS
1 May 2013
The search for a cure

Reviewing Strategies for Draining HIV Reservoirs

Editor's pick
Treatment Action Group
1 May 2013
Pharmaceutical industry

Johnson & Johnson allies with biotech startup on HIV drug in China

Editor's pick
FierceBiotech
1 May 2013
Behaviour change interventions

UNITED STATES: 7 States Trying to Gut Sex Ed and Promote Abstinence

Editor's pick
CDC National Prevention Information Network
1 May 2013
Epidemiology

Egypt has one of the lowest HIV rates: Health and population ministry

Editor's pick
Ahram Online
1 May 2013

HIV Weekly - 1st May 2013

May 2013
New & experimental hepatitis C treatment

Compassionate access to new hepatitis C drugs an "emergency" for European patients

News
30 April 2013
Condoms & lubricant

Why still so few use condoms

Editor's pick
The Atlantic
30 April 2013
HIV testing policies & guidelines

Task force calls for routine HIV testing for all adults

Editor's pick
Reuters
30 April 2013
New & experimental hepatitis C treatment

Second-generation HCV protease inhibitor simeprevir pushes triple therapy cure rate up to 80%

News
30 April 2013
New & experimental hepatitis C treatment

Second-generation protease inhibitor faldaprevir cures up to 80% of hepatitis C

News
30 April 2013
Hepatitis C treatment

Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis

News
30 April 2013
New & experimental HIV treatments

FDA rejects two of the four drugs in Gilead's blockbuster HIV drug Stribild

Editor's pick
FierceBiotech
30 April 2013
Discrimination & the law

HIV-Positive Patient Wins Suit Over Doc’s “Unreasonable Fear”

Editor's pick
Lawyers.com
30 April 2013
The search for a cure

‘Cured of AIDS’? Not Yet

Editor's pick
New York Times
30 April 2013
HIV testing policies & guidelines

Colombian antenatal HIV testing rates reveal health insurance paradox

Editor's pick
Medwire News
29 April 2013
Behaviour change interventions

Let's be more open about the joy of sex

Editor's pick
The Guardian
29 April 2013
New & experimental hepatitis C treatment

Hep C quad regimens quashed, but some components go forward

News
29 April 2013
New & experimental hepatitis C treatment

Daclatasvir + sofosbuvir offers hepatitis C rescue therapy after current standard of care

News
29 April 2013